# The RX Index > The RX Index is the independent GLP-1 decision resource. We help readers decide how to start or switch GLP-1 treatment — comparing providers, treatment paths, pricing, and policies for semaglutide, tirzepatide, Wegovy, Ozempic, Zepbound, Mounjaro, and compounded GLP-1 programs. Recommendations follow our published RX Index Score methodology and are verified against FDA labels, manufacturer pricing, and primary provider sources. We are not a clinic, not a telehealth provider, and not medically affiliated. We may earn commissions from some provider links; affiliate relationships never change which provider we recommend. Every guide leads with the verified answer, names its sources, and carries a dated review stamp. Sitemap: https://therxindex.com/sitemap.xml RSS: https://therxindex.com/feed.xml Editorial standards: https://therxindex.com/editorial-standards/ Methodology: https://therxindex.com/methodology/ ## Core - [Home](https://therxindex.com/): Independent GLP-1 medication research and provider comparisons. - [Find My GLP-1 Path](https://therxindex.com/find-my-path/): 60-second quiz that matches readers to the GLP-1 program that fits their goals, budget, and health situation. - [How Find My Path Works](https://therxindex.com/find-my-path/how-it-works/): What the matching tool asks, how it builds your route, and what it does not do. - [Decision Methodology](https://therxindex.com/methodology/): How we evaluate GLP-1 providers and paths — the named RX Index Score framework. - [All Guides](https://therxindex.com/guides/): Full index of every GLP-1 buyer guide, access playbook, and provider breakdown. - [Research Hub](https://therxindex.com/research/): Primary-source research on GLP-1 statistics, Medicaid coverage, and affordability. ## Provider Comparisons & Reviews - [Ro vs LillyDirect](https://therxindex.com/guides/ro-vs-lilly-direct/): Head-to-head on pricing, eligibility, and fulfillment for the two dominant Zepbound routes. - [Ro vs WeightWatchers Med+](https://therxindex.com/compare/ro-vs-weightwatchers/): Prescription access, coaching, and membership math compared. - [Mochi vs Ro](https://therxindex.com/compare/mochi-vs-ro/): Compounded-first vs brand-first telehealth, nine concrete differences. - [Eden vs Hers](https://therxindex.com/compare/eden-vs-hers/): Two compounded GLP-1 programs compared on price, transparency, and dose ladders. - [Hims vs Hers Weight Loss](https://therxindex.com/compare/hims-vs-hers-weight-loss/): Pricing parity, dose options, and who each serves best. ## Medication Guides - [Best Semaglutide Online](https://therxindex.com/guides/best-semaglutide-online/): Verified providers, prices, and eligibility for brand and compounded semaglutide. - [Best Online Tirzepatide Providers](https://therxindex.com/guides/best-online-tirzepatide-providers/): 8 providers compared by medication type, access, cost structure, and care. - [Ozempic vs Wegovy](https://therxindex.com/guides/ozempic-vs-wegovy/): Same molecule, different labels — how to choose and what insurance covers. - [Zepbound vs Wegovy](https://therxindex.com/guides/zepbound-vs-wegovy/): Head-to-head on efficacy, price, and insurance pathways. - [How to Get GLP-1 Online](https://therxindex.com/guides/how-to-get-glp-1-online/): Three legitimate paths to GLP-1 access in 2026, with cost and caveats. - [How to Get Wegovy HD Online](https://therxindex.com/guides/how-to-get-wegovy-hd-online/): New 7.2 mg dose — where it's available, pricing, and eligibility. - [Zepbound for Sleep Apnea](https://therxindex.com/guides/zepbound-for-sleep-apnea/): FDA indication, coverage, and prior-auth playbook for OSA patients. ## Cost & Coverage - [GLP-1 Superbill Guide](https://therxindex.com/guides/glp-1-superbill-guide/): Step-by-step reimbursement playbook with real superbill templates. - [Foundayo HSA/FSA Providers](https://therxindex.com/guides/foundayo-providers-that-take-hsa-or-fsa/): Verified direct-checkout vs reimbursement routes for HSA/FSA buyers. - [Cheapest GLP-1 Without Insurance](https://therxindex.com/guides/cheapest-glp-1-without-insurance/): Ranked provider list for uninsured buyers, updated monthly. - [GLP-1 Cost Without Insurance](https://therxindex.com/guides/glp-1-cost-without-insurance/): Full pricing matrix across semaglutide, tirzepatide, brand, and compounded. - [Zepbound Savings Card](https://therxindex.com/guides/zepbound-savings-card/): How Eli Lilly's savings program works, who qualifies, and the HSA/FSA conflict. - [Ozempic Savings Card](https://therxindex.com/ozempic-savings-card/): How the Novo Nordisk Ozempic savings program works, eligibility rules, and where to apply. - [Best GLP-1 With Active Savings Card 2026](https://therxindex.com/best-glp-1-with-active-savings-card-2026/): Which FDA-approved GLP-1 programs have active manufacturer savings cards in 2026, qualification rules, and maximum benefit. - [FDA-Approved GLP-1 OOPM Comparison](https://therxindex.com/fda-approved-glp1-out-of-pocket-maximum-comparison/): 2026 out-of-pocket maximum comparison for FDA-approved GLP-1 medications across commercial plans and savings programs. - [How to Appeal a Zepbound Denial](https://therxindex.com/guides/how-to-appeal-a-zepbound-denial/): Insurance denial appeal letter, timeline, and win rates. - [Letter of Medical Necessity for GLP-1](https://therxindex.com/guides/how-to-get-letter-of-medical-necessity-for-glp-1/): LMN template and approval workflow. ## State-Specific Access & Medicaid - [GLP-1 Medicaid Coverage by State](https://therxindex.com/research/glp1-medicaid-coverage-by-state/): Fee-for-service Medicaid obesity coverage, state by state, with coverage-reach math. - [Medicaid GLP-1 Coverage by State (Guide)](https://therxindex.com/research/medicaid-glp-1-coverage-by-state/): Companion guide to the research dataset, with appeal pathways. ## Research & Methodology - [GLP-1 Statistics](https://therxindex.com/research/glp1-statistics/): Primary-source statistics on GLP-1 prescribing, adherence, and market size. - [Research Changelog](https://therxindex.com/research/changelog/): Dated log of every data revision and correction. - [Editorial Standards](https://therxindex.com/editorial-standards/): How we write, who reviews, and how we separate editorial from affiliate. - [Corrections Policy](https://therxindex.com/corrections/): How to report an error and what happens next. ## FSA, HSA & Pre-Tax Benefits - [Section 125 Cafeteria Plan GLP-1 Guide](https://therxindex.com/guides/section-125-cafeteria-plan-glp-1/): How a Section 125 cafeteria plan can pay for GLP-1s pre-tax — FSA, HSA, and HRA routes, 2026 IRS limits, the IRS-flagged wellness-plan scheme, and how to document a claim. - [FSA Grace Period & Rollover Rules for GLP-1](https://therxindex.com/guides/fsa-grace-period-and-rollover-rules-glp-1/): FSA grace period, rollover, and run-out rules for GLP-1s in 2026 — the $680 carryover cap, March 15 deadlines, what qualifies, documentation to avoid a denial, and which providers give you the cleanest paper trail. ## Insurance & Formulary Guides - [What GLP-1 Does Anthem Cover?](https://therxindex.com/guides/what-glp-1-does-anthem-cover/): Anthem lists weight-loss GLP-1s (Wegovy, Zepbound, Foundayo, Saxenda) with a benefit exclusion flag on every row. Diabetes GLP-1s (Ozempic, Mounjaro) generally covered with prior approval. Exact drug-list rows pulled from the Anthem California Traditional Open list, June 2026. PA/BE/QL/ST code decoder, 14-state entity map, Medicare GLP-1 Bridge details, denial decoder, Ro free coverage check. - [What GLP-1 Does Medicare Cover for Diabetes?](https://therxindex.com/guides/what-glp1-does-medicare-cover-for-diabetes/): 2026 Medicare Part D diabetes GLP-1 coverage map. Full drug table (Ozempic pen/pill, Mounjaro, Rybelsus, Trulicity, Victoza/generic liraglutide). The one rule: diabetes = Part D, weight loss = $50 Bridge (two different doors). 3-stage cost structure (deductible -> 25% coinsurance -> $2,100 cap then $0). 5-step plan check with call scripts. Prior-auth documentation checklist. 6-reason denial decoder with fixes. Telehealth trap: Ro/Hims are cash-pay and don't run Medicare benefit; Sesame prescriber-gap path explained. Savings card ban for Medicare (anti-kickback law). 15 FAQs. Last verified June 17, 2026. - [What GLP-1 Does Aetna Cover?](https://therxindex.com/insurance/what-glp1-does-aetna-cover/): Plain-English Aetna coverage map by plan, drug, and diagnosis. Full 8-drug table (Ozempic, Mounjaro, Rybelsus, Trulicity, Wegovy, Zepbound, Foundayo, Saxenda). CVS Caremark formulary timeline (Zepbound dropped July 2025, returns Oct 2026). Employer carve-out explainer, 4-lane framework, PA criteria (BMI 30/27+comorbidity, 6-month program, 5% continuation), Medicare GLP-1 Bridge ($50/month July 2026-Dec 2027), denial decoder (5 types), cash-pay pricing, Aetna Better Health/Medicaid state-specific guide. - [CarelonRx GLP-1 Formulary Guide](https://therxindex.com/guides/best-fda-approved-glp-1-carelonrx-formulary/): Which FDA-approved GLP-1s are on the CarelonRx drug list in 2026, what PA, BE, and QL mean, and how to verify your own coverage. - [Capital Rx GLP-1 Formulary Guide](https://therxindex.com/guides/best-fda-approved-glp-1-capital-rx-formulary/): Which FDA-approved GLP-1s Capital Rx actually covers in 2026 — real tiers, prior-auth rules, and how to confirm Wegovy, Zepbound, or Ozempic for your plan. ## Experimental Drug Alternatives - [Best VK2735 Alternatives](https://therxindex.com/best-vk2735-alternatives/): VK2735 isn't FDA-approved or for sale yet. Ranked comparison of the closest options you can actually get now — Zepbound, Foundayo, Wegovy — by mechanism, cost, and fit. - [Best MariTide Alternatives](https://therxindex.com/best-maritide-alternatives/): MariTide isn't approved yet. Ranked comparison of the closest GLP-1 alternatives you can get in 2026 — by weight loss, dosing, price, and how to start. - [Best Amycretin Alternatives](https://therxindex.com/guides/best-amycretin-alternatives/): Amycretin isn't FDA-approved yet. Closest legal options you can get now — Zepbound, Wegovy pill, Foundayo & more — with real 2026 prices and AARM readiness ratings. - [Best Pemvidutide Alternatives](https://therxindex.com/guides/best-pemvidutide-alternatives/): Pemvidutide isn't approved or for sale. Best alternatives by goal: weight loss, fatty liver, pills, cost — with Pemvidutide-Fit Matrix and what to avoid. - [Best Survodutide Alternatives](https://therxindex.com/guides/best-survodutide-alternatives/): Survodutide isn't FDA-approved. Best alternatives by goal: Zepbound for weight loss, Wegovy pill or Foundayo for pills, Wegovy injection for MASH — with Fit Matrix and what to avoid. - [Best Compounded Semaglutide Alternatives](https://therxindex.com/best-compounded-semaglutide-alternatives/): Compounded semaglutide shortage ended Feb 2025. FDA-approved replacements ranked by legal status, cost ($149-$449/mo), and route — Wegovy pill, Zepbound, Foundayo — with red flags to avoid. - [Best Compounded Tirzepatide Alternatives](https://therxindex.com/guides/best-compounded-tirzepatide-alternatives/): Broad compounding of tirzepatide ended early 2025. Every legal 2026 route with verified prices — Zepbound from $299, Foundayo from $149 — plus 20-question provider checklist and red flags. - [Best Ozempic Alternatives](https://therxindex.com/guides/best-ozempic-alternatives/): Decision matrix by reason (weight loss, diabetes, pill, price, denial) with 2026 verified cash prices, compounding safety timeline, and Ro vs. Sesame vs. direct-buy comparison. - [Best Wegovy Alternatives](https://therxindex.com/guides/best-wegovy-alternatives/): Zepbound beat Wegovy 20.2% vs 13.7% head-to-head (SURMOUNT-5). Full 7-option matrix by reason for switching, dealbreaker table, Medicare GLP-1 Bridge update, and 2026 verified prices. - [Best Zepbound Alternatives](https://therxindex.com/guides/best-zepbound-alternatives/): Decision sorted by why you're switching — cost (stay on $299 vials), needles (Wegovy pill/Foundayo from $149), denial (decode the type first), OSA (don't switch without a clinician), MASH/heart (Wegovy). 2026 compounding rules timeline included. - [Best Mounjaro Alternatives](https://therxindex.com/guides/best-mounjaro-alternatives/): Mounjaro is tirzepatide for diabetes ($1,112/fill). Best weight-loss alternative: Zepbound (same ingredient) from $299. Pills from $149. Compounding 2026 timeline. Diabetes switchers use different path. Verified prices + 11 FAQs. - [Best Saxenda Alternatives](https://therxindex.com/guides/best-saxenda-alternatives/): 5 FDA-approved alternatives to Saxenda (liraglutide): Zepbound from $299, Wegovy from $149 (pill) or $349 (pen), Foundayo from $149, generic liraglutide. STEP 8: Wegovy 15.8% vs Saxenda 6.4%. First generic GLP-1 Aug 2025. 11 FAQs, verified June 2026.